India confirms 50 trials meet standards
This article was originally published in Scrip
Executive Summary
India's health ministry has confirmed that 50 of 157 global clinical trials that were required to be re-evaluated following a court directive have so far been judged to meet all relevant aspects of safety and efficacy, and has recommended that they be allowed to continue in the country.